This paper reviews evidence-based studies for corticosteroids as well as other Phase II and Phase III clinical trials involving potential pharmacological treatments, and replenishment of nutritional deficiencies. The author also briefly reviews the current status of treatments for genetic mutations and gene therapy.
Sculley, M. A., Pandya, S. & Moxley, R. T. 2013. Review of phase II and phase III clinical trials for Duchenne muscular dystrophy. Expert Opinion on Orphan Drugs. 1 (1) p 33 - 36
To access electronically, click here, log in using your Athens username and password and search via the CINAHL database.